Midgard Science

DavosPharma

Upper Saddle River, NJ, United States davos.com From their website, Nov 2026

  • GLP
  • GMP

Work here? Claim this listing

About

DavosPharma coordinates drug development outsourcing for biotech and pharmaceutical companies, with support across discovery, CMC, toxicology, and regulatory strategy. It works with a global network of vetted CROs, CDMOs, and consultants to help clients reach IND submission.

Services

  • Integrated IND Platform

    Manages a coordinated program from CMC and toxicology through regulatory strategy and vendor coordination for IND submission.

  • Discovery

    Coordinates hit-to-lead chemistry, ADME/PK, early biology, in vitro and in vivo pharmacology, and bioanalytical method development through vetted CROs.

  • Small Molecule

    Matches projects involving peptides, HPAPIs, controlled substances, and complex chemistries with CDMOs for process development, scale-up, and manufacturing.

  • Biologics

    Matches biologics programs with CDMOs for analytical development, potency testing, validation, and manufacturing of modalities such as antibodies, gene therapies, RNA-based platforms, vaccines, enzymes, and biosimilars.

  • Drug Product

    Coordinates formulation development, preformulation assessment, tech transfer, validation support, and GMP manufacturing for drug products from capsules to injectables.

  • Toxicology

    Coordinates GLP-compliant toxicology studies, including acute, subchronic, chronic, reproductive and DART, safety pharmacology, and genotoxicity work.

    ADME, DMPK & toxicology

Turnaround
  • 3x faster average CRO onboarding time
  • 10-12 months average time from lab scale familiarization to delivery of Phase 1 API
  • 3x faster average CRO onboarding time compared to teams managing vendor outreach alone
  • 10-12 months our average time from lab scale familiarization to delivery of Phase 1 API

Capabilities

Assays and studies
  • Small molecules
  • Toxicology
  • Peptides
  • ADME
  • Antibodies
  • Fill-finish
23 more
  • Bioanalysis
  • In vivo
  • Analytical development
  • Hit-to-lead
  • ADME/PK
  • Early biology
  • In vitro pharmacology
  • In vivo pharmacology
  • Bioanalytical method development
  • Custom assay development
  • Potency testing
  • Analytical validation
  • Preformulation assessment
  • Acute toxicity
  • Subchronic toxicity
  • Chronic toxicity
  • Reproductive toxicity
  • Developmental toxicity (DART)
  • Hit-to-lead chemistry
  • Early biology studies
  • Developmental toxicity
  • Safety pharmacology
  • Genotoxicity
Scale and capacity
  • Over 100 vetted CDMOs and CROs in the network
  • 80+ INDs filed to date

Modalities and species

Modalities
  • Small molecule
  • Antibody
  • Bispecific
  • ADC
  • Peptide
  • Oligonucleotide
5 more
  • mRNA
  • Viral vector
  • Cell therapy
  • Vaccine
  • Biosimilar

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GLPSelf-reported

    Scope: toxicology studies

  • GMPSelf-reported

    Scope: drug product manufacturing and vetted manufacturing partners

Industries served

  • Biotech
  • Pharmaceutical
  • Academic
  • Industry

Details

Type
CRDMO
Founded
1972
Address
600 E Crescent Ave, Upper Saddle River, NJ 07458, United States
Serves
North America, Europe, Asia, global
Phone
(201) 995-0070

Public records

Biocom California CRO directory
clinical trials, Custom Chemistry, Drug Product, Preclinical Research, process development source

Similar labs